Lv21
130 积分 2023-03-29 加入
新辅助免疫联合化疗治疗非小细胞肺癌病理缓解预测的回顾性研究
1天前
待确认
真实世界回顾性分析免疫新辅助治疗在肺癌中的应用价值
1天前
已完结
Efficacy of disitamab vedotin (RC48) plus tislelizumab and S-1 as first-line therapy for HER2-overexpressing advanced stomach or gastroesophageal junction adenocarcinoma: A multicenter, single-arm, phase II trial (RCTS)
3个月前
已完结
Updated survival results of BBCAPX-II: Sintilimab combined with bevacizumab and CapeOx as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer
4个月前
已完结
491P Neoadjuvant nivolumab in early stage colorectal cancer
6个月前
已完结
Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): An open-label, randomized, phase 2 study
6个月前
已完结
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
7个月前
已完结
Biomarkers in Colorectal Cancer: The Role of Translational Proteomics Research
7个月前
已完结
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
7个月前
已完结
乳腺癌术后放疗靶区勾画和计划设计指南
9个月前
已完结
皖公网安备34019202002308
